title: Influence of racemic higenamine on the sinus node.
abstract: The aim of this study was to explore the mechanism of racemic higenamine in the treatment of sick sinus syndrome (SSS). A total of 40 New Zealand rabbits were randomly divided into normal sinus node and damaged sinus node (SND) groups, and each group was randomly divided into treatment and control groups (n=10). The SND model was established by formaldehyde wet dressing of the sinus node area. The treatment groups were administered an intravenous infusion of 0.04 mg/kg racemic higenamine via the marginal ear vein within 5 min. The electrophysiological indicators of sinoatrial function, including the sinus node recovery time (SNRT), corrected sinus node recovery time (CSNRT), total sinoatrial conduction time (TSACT) and sinus cycle length (SCL), were determined before and 20 min after medication and the changes in these indicators were evaluated. The two control groups were administered 10 ml physiological saline. Following the administration of racemic higenamine, the SNRT, CSNRT, TSACT and SCL in the normal sinus node and SND groups were significantly shortened compared with those in the control groups (P<0.01). The electrophysiological influence of racemic higenamine on sinoatrial function in the SND group was significantly greater than that in the normal sinus node group (P<0.01), and its effect in the treatment of arrhythmia caused by a damaged sinus node was statistically significant (P<0.05). The main electrophysiological mechanism of racemic higenamine in the treatment of SSS was the enhancement of sinus node self-discipline and improvement of sinoatrial and atrioventricular conduction function.
authors: Department of Emergency Medicine, Yantaishan Hospital, Yantai, Shandong 264001,  P.R. China.
authors: Fengxia
authors: F
authors: Yu
authors: Lingting
authors: L
authors: Kong
authors: Shujuan
authors: S
authors: Wang
keywords: racemic higenamine; sick sinus syndrome; sinoatrial conduction time; sinus node recovery time
references: Biol Pharm Bull. 2012;35(7):1041-7
references: 22791150
references: Int Immunopharmacol. 2006 Feb;6(2):226-33
references: 16399627
references: Planta Med. 2001 Oct;67(7):619-22
references: 11582538
references: Apoptosis. 2006 Jul;11(7):1091-100
references: 16703264
references: Apoptosis. 2012 May;17(5):463-74
references: 22183510
references: Planta Med. 1997 Apr;63(2):130-2
references: 9140225
references: J Ethnopharmacol. 2012 Mar 6;140(1):166-78
references: 22265931
references: Circulation. 1972 Jan;45(1):140-58
references: 4108657
references: J Tradit Chin Med. 1984 Jun;4(2):133-40
references: 6567726
references: Planta Med. 2002 Apr;68(4):326-9
references: 11988856
references: Acta Pharmacol Sin. 2008 Oct;29(10):1187-94
references: 18817623
references: J Thorac Cardiovasc Surg. 1973 Jun;65(6):841-50
references: 4704236
references: Bioorg Med Chem Lett. 2008 Jul 15;18(14):4110-4
references: 18556200
references: Thromb Res. 2007;120(1):81-6
references: 17020781
references: Circulation. 1978 Oct;58(4):706-14
references: 688581
references: Jpn J Pharmacol. 2000 Nov;84(3):244-51
references: 11138724
references: Circulation. 1998 May 12;97(18):1796-801
references: 9603534
references: Jpn J Pharmacol. 1994 Sep;66(1):75-80
references: 7861670